ScholarLens Back to search
2021•Alimentary Pharmacology & TherapeuticsOpen access

Letter: ustekinumab for the treatment of post‐surgical and refractory Crohn's disease

Antonio Tursi, Giammarco Mocci, Marcello Picchio, Walter Elisei, Giovanni Maconi

Open full text 9 citations

Abstract

LINKED CONTENT This article is linked to Biemans et al paper. To view this article, visit https://doi.org/10.1111/apt.15745

Open-access reader

About this research paper

What this paper is about

LINKED CONTENT This article is linked to Biemans et al paper. To view this article, visit https://doi.org/10.1111/apt.15745

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

LINKED CONTENT This article is linked to Biemans et al paper. To view this article, visit https://doi.org/10.1111/apt.15745

Key concepts: Ustekinumab, Medicine, Refractory (planetary science), Crohn's disease, Crohn disease, Disease, Gastroenterology, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Letter: ustekinumab for the treatment of post‐surgical and refractory Crohn's disease — Research Paper | ScholarLens